-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
DENV-IN-5
Category | Human immunodeficiency Virus (HIV) |
CAS | 2375781-06-7 |
Description | DENV-IN-5 is a dengue virus (DENV) inhibitor with EC50s of 1.47, 9.23, 7.08 and 8.91 μM against DENV-I - IV replication, respectively. DENV-IN-5 also inhibits HIV-1IIIB strain with an EC50 of 0.1512 μM. |
Product Information
Synonyms | 4(3H)-Pyrimidinone, 2-[[[4-chloro-5-(3,4-difluorophenyl)-1H-pyrazol-3-yl]methyl]thio]-6-(cyclohexylmethyl)-5-ethyl-; 2-[[[4-Chloro-5-(3,4-difluorophenyl)-1H-pyrazol-3-yl]methyl]thio]-6-(cyclohexylmethyl)-5-ethyl-4(3H)-pyrimidinone; 2-(((4-Chloro-5-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methyl)thio)-6-(cyclohexylmethyl)-5-ethylpyrimidin-4(3H)-one |
IUPAC Name | 2-[[4-chloro-3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylsulfanyl]-4-(cyclohexylmethyl)-5-ethyl-1H-pyrimidin-6-one |
Molecular Weight | 478.99 |
Molecular Formula | C23H25ClF2N4OS |
Canonical SMILES | CCC1=C(N=C(NC1=O)SCC2=C(C(=NN2)C3=CC(=C(C=C3)F)F)Cl)CC4CCCCC4 |
InChI | InChI=1S/C23H25ClF2N4OS/c1-2-15-18(10-13-6-4-3-5-7-13)27-23(28-22(15)31)32-12-19-20(24)21(30-29-19)14-8-9-16(25)17(26)11-14/h8-9,11,13H,2-7,10,12H2,1H3,(H,29,30)(H,27,28,31) |
InChIKey | GYGFJKYRVOOELP-UHFFFAOYSA-N |
Boiling Point | 613.8±65.0 °C at 760 mmHg |
Purity | ≥98% |
Density | 1.43±0.1 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | Solid |
Storage | Store at 2-8 °C |